TRPHARM

Industry · 9 registered clinical trials.

Status	Trial	Phase	Started
Unknown	Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunog Adenosine Deaminase Deficiency	—	2021-12-03
Unknown	Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Adult Patients With Pulmonary Alveolar Pr Pulmonary Alveolar Proteinosis	—	2021-08-16
Unknown	Observational Study Evaluating the Prevalence of Enzyme Deficiency in Pulmonology Clinics (ADA) Bronchiectasis, Adenosine Deaminase Deficiency, Pulmonary Disease	—	2021-06-17
Unknown	A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX) Xanthomatosis, Cerebrotendinous	—	2019-12-01
Terminated	An Observational Study for Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease CTX - Cerebrotendinous Xanthomatosis	—	2019-10-19
Unknown	Investigation of ADA Enzyme Deficiency Adenosine Deaminase Deficiency	—	2019-10-10
Unknown	The Prevalence of CTX Disorder in Juvenile Cataract Cases in Turkey Cerebrotendinous Xanthomatosis	—	2018-06-01
Withdrawn	Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator Healthy	Phase 1	2017-12-01
Available	A Compassionate Use Program to Provide Access to Sodium Thiosulfate Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma	—	—